Literature DB >> 18327819

Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features.

Mahitosh Mandal1, Jeffery N Myers, Scott M Lippman, Faye M Johnson, Michelle D Williams, Suresh Rayala, Kazufumi Ohshiro, David I Rosenthal, Randal S Weber, Gary E Gallick, Adel K El-Naggar.   

Abstract

BACKGROUND: Epithelial-mesenchymal transformations (EMT) are critical for the invasion, progression, and metastasis of epithelial carcinogenesis. The role of EMT in head and neck squamous carcinoma (HNSC) tumorigenesis remains unexplored. In the current study, the expressions of several factors associated with the induction of EMT in HNSC cell lines and tumor specimens were investigated to define their functional and pathologic role in HNSC.
METHODS: Eleven HNSC cell lines and 50 primary tumor tissue specimens formed the materials of this study. Western blot analysis as well as immunohistochemical, and functional techniques were used to assess the status of activated Src (p-Src), E-cadherin, and vimentin in both cell lines and tumor tissues and the results were correlated with patients' clinicopathologic parameters.
RESULTS: The results demonstrated the inverse expression of p-Src and E-cadherin in the majority of cell lines and in primary tumor tissues compared with normal squamous mucosa. Elevated levels of p-Src were accompanied by down-regulation of E-cadherin and the expression of vimentin in epithelial tumor cells. In vitro inhibition of Src led to E-cadherin reexpression and increased cell contact in squamous carcinoma cell lines. Immunophenotypic analysis of these markers in primary tumor tissues demonstrated a significant correlation between increased p-Src, decreased E-cadherin, and vimentin expression and aggressive tumor features including penetrating invasive fronts, high-grade sarcomatoid transformation, and lymph node metastasis.
CONCLUSIONS: The results of the current study indicate that Src and E-cadherin may play an important role in EMT, invasion, and aggressive clinicopathologic features of HNSC. These proteins may be targeted for the therapeutic intervention of patients with HNSC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18327819     DOI: 10.1002/cncr.23410

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  68 in total

Review 1.  Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment.

Authors:  Alexandra Lucs; Benjamin Saltman; Christine H Chung; Bettie M Steinberg; David L Schwartz
Journal:  Head Neck       Date:  2012-01-27       Impact factor: 3.147

2.  Phenotypic transition of tumor cells between epithelial- and mesenchymal-like state during adaptation to acidosis.

Authors:  Yongjun Zhang; Lili Xu; Ping Wang; Huanzhang Jian; Xianghua Shi; Min Jia; Lijun Mo; Zhiming Hu; Hongwei Li; Jinlong Li
Journal:  Cell Cycle       Date:  2019-06-29       Impact factor: 4.534

3.  Benzyl isothiocyanate inhibits HNSCC cell migration and invasion, and sensitizes HNSCC cells to cisplatin.

Authors:  M Allison Wolf; Pier Paolo Claudio
Journal:  Nutr Cancer       Date:  2014-01-21       Impact factor: 2.900

4.  Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis.

Authors:  L Jin; J Chun; C Pan; G N Alesi; D Li; K R Magliocca; Y Kang; Z G Chen; D M Shin; F R Khuri; J Fan; S Kang
Journal:  Oncogene       Date:  2017-02-20       Impact factor: 9.867

5.  Cigarette smoke extract stimulates epithelial-mesenchymal transition through Src activation.

Authors:  Hongqiao Zhang; Honglei Liu; Zea Borok; Kelvin J A Davies; Fulvio Ursini; Henry Jay Forman
Journal:  Free Radic Biol Med       Date:  2012-02-04       Impact factor: 7.376

Review 6.  Sheep, wolf, or werewolf: cancer stem cells and the epithelial-to-mesenchymal transition.

Authors:  Jeffrey T Chang; Sendurai A Mani
Journal:  Cancer Lett       Date:  2013-03-14       Impact factor: 8.679

7.  The dual kinase complex FAK-Src as a promising therapeutic target in cancer.

Authors:  Victoria Bolós; Joan Manuel Gasent; Sara López-Tarruella; Enrique Grande
Journal:  Onco Targets Ther       Date:  2010-06-24       Impact factor: 4.147

8.  SNAI1 expression and the mesenchymal phenotype: an immunohistochemical study performed on 46 cases of oral squamous cell carcinoma.

Authors:  Joerg Schwock; Grace Bradley; James C Ho; Bayardo Perez-Ordonez; David W Hedley; Jonathan C Irish; William R Geddie
Journal:  BMC Clin Pathol       Date:  2010-02-05

9.  Numb regulates cell-cell adhesion and polarity in response to tyrosine kinase signalling.

Authors:  Zezhou Wang; Shelley Sandiford; Chenggang Wu; Shawn Shun-Cheng Li
Journal:  EMBO J       Date:  2009-07-16       Impact factor: 11.598

10.  Improving Response Rates to EGFR-Targeted Therapies for Head and Neck Squamous Cell Carcinoma: Candidate Predictive Biomarkers and Combination Treatment with Src Inhibitors.

Authors:  Ann Marie Egloff; Jennifer Rubin Grandis
Journal:  J Oncol       Date:  2009-07-14       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.